Your trusted source for investing success

Tag: infectious diseases

ImmunoPrecise to Acquire QVQ Holdings BV and Reports Growth Results

ImmunoPrecise (TSXV:IPA) has announced it has signed a binding letter of intent with QVQ Holdings whereby Immuno will acquire all of the issued and outstanding shares of QVQ.

As quoted in the press release:

Currently, U-Protein Express B.V., a wholly owned subsidiary of the Company owns 37% of the issued and outstanding

CURE Pharmaceutical Subsidiary Completes Critical Milestone

CURE Pharmaceutical announced its subsidiary Oak Therapeutics completed a milestone as part of their research contract with the National Institutes of Health and National Institute of Allergy and Infectious Diseases to develop 300mg of Isoniazid in a rapidly dissolving Oral Dissolvable Strip as an antituberculosis treatment.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
5 Top NASDAQ Biotech Stocks: Viking Therapeutics Leads the Week